Korro Bio, Inc. Common Stock KRRO
$10.53
+5.46%
at last close
Analyst Consensus
- Consensus Rating
- Buy (9 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $19.33
- Implied Upside
- +83.7%
- Price Target Range
- $8.00 – $30.00
- Analysts (12 mo)
- 11
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-20 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $15 |
| 2026-05-19 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $20 → $15 |
| 2026-05-18 | CitigroupYigal Nochomovitz |
Initiates coverage on | Buy | $21 |
| 2026-03-13 | Cantor FitzgeraldSteve Seedhouse |
Maintains | Overweight | $21 → $22 |
| 2026-03-13 | Raymond JamesSteven Seedhouse |
Upgrades | Market perform → Outperform | $23 |
| 2026-02-19 | Clear StreetBill Maughan |
Upgrades | Hold → Buy | $10 → $18 |
| 2026-02-17 | William BlairMyles Minter |
Upgrades | Market perform → Outperform | — |
| 2026-01-29 | Chardan CapitalKeay Nakae |
Upgrades | Neutral → Buy | $7 → $15 |
| 2026-01-29 | HC Wainwright & Co.Mitchell S. Kapoor |
Upgrades | Neutral → Buy | $20 |
| 2026-01-29 | Piper SandlerYasmeen Rahimi |
Upgrades | Neutral → Overweight | $11 → $30 |
| 2026-01-28 | OppenheimerKostas Biliouris |
Upgrades | Perform → Outperform | $22 |
| 2026-01-28 | Cantor FitzgeraldSteve Seedhouse |
Upgrades | Neutral → Overweight | $21 |
| 2025-11-14 | Jones TradingCatherine Novack |
Downgrades | Buy → Hold | — |
| 2025-11-13 | William BlairMyles Minter |
Downgrades | Outperform → Market perform | — |
| 2025-11-13 | RBC CapitalLuca Issi |
Downgrades | Outperform → Sector perform | $85 → $8 |
| 2025-11-13 | Cantor FitzgeraldSteve Seedhouse |
Downgrades | Overweight → Neutral | — |
| 2025-11-13 | Chardan CapitalKeay Nakae |
Downgrades | Buy → Neutral | $25 → $7 |
| 2025-11-13 | HC Wainwright & Co.Mitchell S. Kapoor |
Downgrades | Buy → Neutral | — |
| 2025-10-31 | Clear StreetBill Maughan |
Initiates coverage on | Buy | $93 |
| 2025-08-13 | Chardan CapitalKeay Nakae |
Maintains | Buy | $25 |
| 2025-08-13 | Raymond JamesSteven Seedhouse |
Maintains | Strong buy | $153 → $147 |
| 2025-08-13 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $100 → $90 |
| 2025-07-24 | HC Wainwright & Co.Mitchell Kapoor |
Reiterates | Buy | $100 |
| 2025-05-13 | Chardan CapitalKeay Nakae |
Maintains | Buy | $25 |
| 2025-05-13 | OppenheimerAndreas Argyrides |
Maintains | Outperform | $155 → $90 |
| 2025-05-08 | HC Wainwright & Co.Mitchell Kapoor |
Maintains | Buy | $115 → $100 |
| 2025-04-29 | Cantor FitzgeraldSteven Seedhouse |
Initiates coverage on | Overweight | $74 |
| 2025-04-16 | Chardan CapitalKeay Nakae |
Initiates coverage on | Buy | $25 |
| 2025-03-20 | HC Wainwright & Co.Mitchell Kapoor |
Reiterates | Buy | $115 |
| 2025-03-19 | RBC CapitalLuca Issi |
Maintains | Outperform | $105 → $95 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $10.53
- Market Cap
- $146.96 million
- 52-Week Range
- $5.20 – $55.89
- Average Volume
- 143K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.